FUTURE ONCOLOGY
Volume 3 # 7/8 November/December 1997
State-of the-Art in the
Management of Cancer
Cancer of the Central Nervous System-Part I
Epidemiology, Etiology, Diagnosis and Prognosis
Worldwide Epidemiology of Primary CNS Tumors
USA Epidemiology
Secondary CNS Tumors
Epidemiology of Metastatic CNS Cancer
Etiology of Primary Tumors of the CNS
- Hereditary/Familial Factors
- Environmental Factors
- Viral Infections
- Other Factors
Molecular Genetics and Molecular Biology of Primary Brain
Tumors
Gene Factors
- Chromosomal/gene abnormalities
- Gene amplification
Growth Factors
Diagnosis
- Neuroimaging
- Stereotactic Techniques
- In Vitro Tests
- Other Tests
Tumor Staging
Prognosis
Meeting Coverage
Cancer of the Central Nervous System
From the American Association of Cancer
Research Conference
June 7-11, 1997, San Diego, CA
Targeting Regional Metastases of Brain Tumors
Targeting Protease Production
- Peptidyl methyl ketone
- Maramistat
- Carboxy-amido-triazole (CAI)
Mechanisms of Drug-Induced Apoptosis
Telomerase in Cancers of the Nervous System
Herpes Vectors for Brain Tumor Therapy
- Basic HSV Gene Therapy Vector
- Improved HSV Recombinant Vector
- HSV-1 Amplicon
- Helper Virus-free Packaging System
Farnesyltransferase Inhibitors and Anti-Ras Therapy
Targeting p53-Deficient Cells With Adenovirus Mutants
A Report on Molecular Medicine of Cancer, A
Genetic Disease
from the Ninth Annual Usha Mahajani
Symposium
at the Salk Institute, September 5, 1997
Methylation and Epigenetic Instability in the Development
of Cancer
Imprinted Genes and Childhood Tumors
Methylation of Normal Genes
Hypermethylation
- Mismatch repair genes
- Epimutations
- Loss of a protective mechanism
Chromosomal Translocations in Cancer
Bcl-2
Genes Involved in the Pre-initiation of Cancer
Emerging Cytogenetic Technologies to Detect Quantitative
Chromosome Changes
BRCA1 and BRCA2 Genes in Breast and Ovarian Cancer
- Mutations Vary by Geography
- Actionable Cancer-propensity Genes
- Sporadic Cancers
- Gene Therapy
|